Table 3.
Measure | Normotension and APOE-ε4−, n=126 | Hypertension or APOE- ε4+, n=391 | Hypertension and APOE- ε4+, n=108 | APOE by Hypertension, P-Valueb |
---|---|---|---|---|
Least Square Means (Standard Error)a | ||||
Trail-Making Test, seconds | ||||
Part A | 59.9 (3.4)c | 62.9 (2.4)c | 66.2 (3.3)c | .03 |
Part B | 156.6 (7.7) | 169.7 (5.7) | 185.4 (7.6) | <.001 |
Part B–A | 98.5 (6.5) | 109.6 (4.8) | 122.1 (6.4) | <.001 |
Hopkins Verbal Learning Test | ||||
Delayed recall | 6.1 (0.4)c | 5.6 (0.3)c | 4.8 (0.4) | <.001 |
Recognition | 11.8 (0.3)c | 11.4 (0.2)c | 11.0 (0.3) | .002 |
Blood flow velocity, cm/s | 42.6 (1.6)c | 42.9 (1.3)c | 42.0 (1.7)c | .61 |
CO2 vasoreactivity, cm/s per mmHg/partial pressure of CO2mmHg x10−2 | 1.06 (0.07)c | 1.09 (0.05)c | 0.97 (0.07) | .01 |
Adjusted for age, sex, race, body mass index, stroke, systolic blood pressure, and educational level.
Obtained from models adjusted for the same covariates with the interaction parameter (APOE by hypertension).
Not significantly different from each other (after adjusting for pairwise multiple testing).